Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Tom Frohlich | Chief Executive Officer | 2025-05-16 | 6,000 | $7.40 | $44.40kBuy |
Benjamin T. Dake | Officer Title President Chief Operating Officer and Secretary | 2024-08-01 | 1,507 | $1.74 | $2.62kBuy |
Benjamin T. Dake | Officer Title President Chief Operating Officer and Secretary | 2024-07-31 | 11,454 | $1.74 | $19.93kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ra Capital Management LP | 1,109.96% | 9,192,092 | $84.48M | Institution |
Sofinnova Investments Inc | 453.87% | 3,758,686 | $34.54M | Institution |
Sofinnova Venture Partners X LP | 453.87% | 3,758,686 | $34.54M | Insider |
Maha Katabi | 453.87% | 3,758,686 | $34.54M | Insider |
Fairmount Funds Management LLC | 388.87% | 3,220,368 | $29.60M | Insider |
Atlas Venture Fund XII LP | 281.10% | 2,327,909 | $21.39M | Insider |
Tcg Crossover Management LLC | 270.58% | 2,240,809 | $20.59M | Institution |
Cormorant Asset Management LP | 245.21% | 2,030,691 | $18.66M | Insider |
David S. Grayzel | 217.26% | 1,799,232 | $16.53M | Insider |
Atlas Venture Life Science Advisors LLC | 217.26% | 1,799,232 | $16.53M | Institution |